Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04771156 · ClinicalTrials.gov registry record · Phase 4

Ketorolac in Palatoplasty

A Phase 4 study of Cleft Lip and Palate, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
Phase 4
Development phase
74
Enrollment target
1
Study location

NCT04771156: Recruiting Phase 4 study of Cleft Lip and Palate, sponsored by The University of Texas Health Science Center, Houston.

NCT04771156 is a Phase 4 study of Cleft Lip and Palate that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 74 participants, below the 209-participant average among 5 other Cleft Lip and Palate trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04771156, a Phase 4 study of Cleft Lip and Palate, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
Phase 4
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

Primary Outcome

This will be measured in mL's of fluids

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Ketorolac

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2021-09-17
Est. Completion 2027-04-01
Phase Phase 4

What NCT04771156 shows while recruiting

NCT04771156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 209-participant average among 5 other Cleft Lip and Palate trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Cleft Lip and Palate appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04771156 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT04771156 about?

NCT04771156 is a clinical study titled "Ketorolac in Palatoplasty". The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

What is the current status of trial NCT04771156?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2021-09-17. Estimated completion is 2027-04-01.

What conditions does trial NCT04771156 study?

This clinical trial studies the following conditions: Cleft Lip and Palate.

What interventions are being tested in trial NCT04771156?

The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG).

Who is sponsoring clinical trial NCT04771156?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04771156 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cleft Lip and Palate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT05057702 · 74 participants · NA

    Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04771156, the US trial registry maintained by the National Library of Medicine. NCT04771156 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.